Emmes sits at the intersection of the public and private healthcare sectors.
Our clients include biopharmaceutical companies, government agencies, foundations, academic institutions, and other non-profit organizations.
As a full service CRO, our ongoing collaborations with biopharmaceutical companies help bring treatments to market that make an enormous impact on patients and human health worldwide. We serve pharmaceutical companies and biotechs of all sizes, making sure we tailor our solutions to their individual needs.
Emmes also supports the research efforts of numerous government agencies, including the National Institutes of Health (NIH), Food and Drug Administration (FDA), Department of Defense (DOD), Department of Health and Human Services (HHS), Biomedical Advanced Research and Development Authority (BARDA) and the World Health Organisation (WHO).
"We take great pride in having partnered with 15 of the top 25 biopharma companies in the past three years. These collaborations stand as a testament to our integral role in advancing impactful research and development. At Emmes, we are steadfast in our dedication to fostering innovative partnerships, contributing significantly to the progress of healthcare and the well-being of global communities.”
Kristin Judge
Chief Growth Officer, Emmes Biopharma
We are especially proud of our enduring relationship with the National Institutes of Health (NIH). Emmes has provided clinical research services for more than half of the institutes inside NIH across a broad range of therapeutic areas and study types.
Through our engagement with the NIH we have gained significant experience conducting research to support treatments and vaccines during epidemics and pandemics such as HIV-AIDs, MERS, SARS, Ebola, H1NI, COVID-19, and Influenza.
Emmes’ client collaboration
